140 related articles for article (PubMed ID: 28990814)
21. Isobavachalcone isolated from
Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
[No Abstract] [Full Text] [Related]
22. Fucoxanthin and Its Metabolite Fucoxanthinol Do Not Induce Browning in Human Adipocytes.
Rebello CJ; Greenway FL; Johnson WD; Ribnicky D; Poulev A; Stadler K; Coulter AA
J Agric Food Chem; 2017 Dec; 65(50):10915-10924. PubMed ID: 29172481
[TBL] [Abstract][Full Text] [Related]
23. An integrin beta4-EGFR unit promotes hepatocellular carcinoma lung metastases by enhancing anchorage independence through activation of FAK-AKT pathway.
Leng C; Zhang ZG; Chen WX; Luo HP; Song J; Dong W; Zhu XR; Chen XP; Liang HF; Zhang BX
Cancer Lett; 2016 Jun; 376(1):188-96. PubMed ID: 26996299
[TBL] [Abstract][Full Text] [Related]
24. Anti-neoplastic effects of fucoxanthin and its deacetylated product, fucoxanthinol, on Burkitt's and Hodgkin's lymphoma cells.
Tafuku S; Ishikawa C; Yasumoto T; Mori N
Oncol Rep; 2012 Oct; 28(4):1512-8. PubMed ID: 22859062
[TBL] [Abstract][Full Text] [Related]
25. Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer.
Sun C; Zargham R; Shao Q; Gui X; Marcus V; Lazaris A; Salman A; Metrakos P; Qu X; Gao Z
Pathol Res Pract; 2014 Oct; 210(10):668-74. PubMed ID: 25041835
[TBL] [Abstract][Full Text] [Related]
26. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites.
Asai A; Sugawara T; Ono H; Nagao A
Drug Metab Dispos; 2004 Feb; 32(2):205-11. PubMed ID: 14744942
[TBL] [Abstract][Full Text] [Related]
27. α-Lipoic acid sensitizes lung cancer cells to chemotherapeutic agents and anoikis via integrin β1/β3 downregulation.
Puchsaka P; Chaotham C; Chanvorachote P
Int J Oncol; 2016 Oct; 49(4):1445-56. PubMed ID: 27431988
[TBL] [Abstract][Full Text] [Related]
28. Delayed caspase-8 activation and enhanced integrin β1-activated FAK underpins anoikis in oesophageal carcinoma cells harbouring mt p53-R175H.
Fanucchi S; Veale RB
Cell Biol Int; 2011 Aug; 35(8):819-26. PubMed ID: 21426305
[TBL] [Abstract][Full Text] [Related]
29. An altered fibronectin matrix induces anoikis of human squamous cell carcinoma cells by suppressing integrin alpha v levels and phosphorylation of FAK and ERK.
Kamarajan P; Kapila YL
Apoptosis; 2007 Dec; 12(12):2221-31. PubMed ID: 17879163
[TBL] [Abstract][Full Text] [Related]
30. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
31. Focal adhesion kinase is upstream of phosphatidylinositol 3-kinase/Akt in regulating fibroblast survival in response to contraction of type I collagen matrices via a beta 1 integrin viability signaling pathway.
Xia H; Nho RS; Kahm J; Kleidon J; Henke CA
J Biol Chem; 2004 Jul; 279(31):33024-34. PubMed ID: 15166238
[TBL] [Abstract][Full Text] [Related]
32. The PI3K/Akt pathway is involved in procyanidin-mediated suppression of human colorectal cancer cell growth.
Choy YY; Fraga M; Mackenzie GG; Waterhouse AL; Cremonini E; Oteiza PI
Mol Carcinog; 2016 Dec; 55(12):2196-2209. PubMed ID: 26774105
[TBL] [Abstract][Full Text] [Related]
33. CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis.
Xiao YC; Yang ZB; Cheng XS; Fang XB; Shen T; Xia CF; Liu P; Qian HH; Sun B; Yin ZF; Li YF
Cancer Lett; 2015 May; 361(1):22-32. PubMed ID: 25687885
[TBL] [Abstract][Full Text] [Related]
34. SAHA/TRAIL combination induces detachment and anoikis of MDA-MB231 and MCF-7 breast cancer cells.
Lauricella M; Ciraolo A; Carlisi D; Vento R; Tesoriere G
Biochimie; 2012 Feb; 94(2):287-99. PubMed ID: 21835222
[TBL] [Abstract][Full Text] [Related]
35. Jinfukang regulates integrin/Src pathway and anoikis mediating circulating lung cancer cells migration.
Que ZJ; Yang Y; Liu HT; Shang-Guan WJ; Yu P; Zhu LH; Li HG; Liu HM; Tian JH
J Ethnopharmacol; 2021 Mar; 267():113473. PubMed ID: 33068649
[TBL] [Abstract][Full Text] [Related]
36. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells.
Zhang Q; Li XT; Chen Y; Chen JQ; Zhu JY; Meng Y; Wang XQ; Li Y; Geng SS; Xie CF; Wu JS; Zhong CY; Han HY
Cancer Chemother Pharmacol; 2018 Jun; 81(6):969-977. PubMed ID: 29594332
[TBL] [Abstract][Full Text] [Related]
37. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells.
Maeda H; Hosokawa M; Sashima T; Takahashi N; Kawada T; Miyashita K
Int J Mol Med; 2006 Jul; 18(1):147-52. PubMed ID: 16786166
[TBL] [Abstract][Full Text] [Related]
38. Tubeimoside V sensitizes human triple negative breast cancer MDA-MB-231 cells to anoikis via regulating caveolin-1-related signaling pathways.
Wang K; Zhu X; Chen Y; Yin Y; Ma T
Arch Biochem Biophys; 2018 May; 646():10-15. PubMed ID: 29580948
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effects of fucoxanthinol on the viability of human breast cancer cell lines MCF-7 and MDA-MB-231 are correlated with modulation of the NF-kappaB pathway.
Rwigemera A; Mamelona J; Martin LJ
Cell Biol Toxicol; 2014 Jun; 30(3):157-67. PubMed ID: 24760606
[TBL] [Abstract][Full Text] [Related]
40. Curcumin and Colorectal Cancer: From Basic to Clinical Evidences.
Pricci M; Girardi B; Giorgio F; Losurdo G; Ierardi E; Di Leo A
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
